Johnson And Johnson Vaccine News
- All
- News
- Videos
-
Still In Talks With India Over COVID-19 Vaccine: Johnson & Johnson
India's drug regulator said on Monday that Johnson & Johnson withdrew its proposal seeking accelerated approval of its COVID-19 vaccine in the country, without giving additional details, according to a report by news agency Reuters.
-
Johnson & Johnson Forecasts $2.5 Billion In COVID-19 Vaccine Sales
Johnson & Johnson on Wednesday forecast just $2.5 billion in 2021 sales of its COVID-19 vaccine, which has fallen way behind rival shots from Pfizer and Moderna as the company deals with vaccine production issues and safety concerns.
-
Still In Talks With India Over COVID-19 Vaccine: Johnson & Johnson
India's drug regulator said on Monday that Johnson & Johnson withdrew its proposal seeking accelerated approval of its COVID-19 vaccine in the country, without giving additional details, according to a report by news agency Reuters.
-
Johnson & Johnson Forecasts $2.5 Billion In COVID-19 Vaccine Sales
Johnson & Johnson on Wednesday forecast just $2.5 billion in 2021 sales of its COVID-19 vaccine, which has fallen way behind rival shots from Pfizer and Moderna as the company deals with vaccine production issues and safety concerns.
